Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 747)
Posted On: 09/05/2020 11:12:38 PM
Post# of 155592
Posted By: CGC
Sorry if a duplicate:
Article in Targeted Oncology (Per website: Targeted Therapies in Oncology is dedicated to providing oncology healthcare professionals with leading edge research results and treatment strategies for the use of targeted therapies and immunotherapies to improve outcomes in patients with cancer.)

Leronlimab Moving Toward Breakthrough Designation With Positive mTNBC Data

The FDA has recommended that a preliminary meeting for a potential Breakthrough Therapy designation be requested for leronlimab as a treatment of patients with metastatic triple-negative breast cancer, based on positive data from a phase Ib/II study.

https://www.targetedonc.com/view/leronlimab-m...mtnbc-data













(3)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site